gut microbiota

AI-powered approach helps researchers to model the infant microbiota

The findings of a recent study show that Q-net can accurately predict the long-term trajectories of gut microbes and identify patterns indicative of future cognitive deficits.

Infant gut microbiota has its own circadian rhythm

The findings of a recent study suggest that the infant gut microbiota begins to develop circadian rhythms soon after birth, with diet having minimal influence on these microbial patterns.

Nestlé Health Science acquires VOWST Assets

VOWST is the first and only orally administered microbiota-based therapeutic approved by the U.S. FDA for the prevention of recurrent Clostridioides difficile infection in adults.

Gut microbes may contribute to autoimmune kidney disease

The findings of a recent study reveal how gut bacteria modify immune molecules in ways that lead to the development of IgA nephropathy.

Industrial societies may be losing gut microbes that help digest plants

The findings of a recent study suggest that Ruminococcus bacteria were more prevalent in ancient human populations and non-industrialized societies, likely due to the high dietary fiber intake.

Gut microbiota may shape a newborn’s immune system through serotonin production

The findings of a recent study suggest that the infant microbiota produces neurotransmitters that are required for the development of the immune system.

The interplay of diet and the microbiota may influence gut inflammation

The results of a recent study suggest that certain dietary changes can counteract bacterial functions that promote disease. The findings thus underscore the importance of examining microbial functions to understand…

Microbial signature linked to improved response to immunotherapy in older people

The findings of a recent study highlight the importance of considering age-related immune changes and gut microbiota composition for developing personalized immunotherapy approaches.

Microbial metabolites promote colon cancer by suppressing anti-tumor responses

A recent study demonstrated causation between microbial DCA metabolism and anti-tumor CD8+ T cell response in colorectal cancer.

Biompharma’s Bi104 Receives FDA Orphan Drug Designation for Angelman Syndrome Treatment

Bi104 is a microbiome-modifying biologic designed to diversify and modulate the gut microflora and metabolite profile.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top